Resolvex Pharmaceuticals Inc.
5Patents
4Active
5Granted
39Portfolio score
Filing activity: Jun 13, 2003 → Dec 16, 2018 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7378444B2 | Analogues of lipid mediators derived from omega-3 PUFAs and methods of use | Chemistry; Metallurgy | 17 | Expired |
| US7595341B2 | Analogues of lipid mediators derived from ω-3 PUFAs and methods of use | Chemistry; Metallurgy | 5 | Active |
| US9725406B1 | Substituted hydroxystilbenes and their therapeutic applications | Chemistry; Metallurgy | 1 | Active |
| US11000485B2 | Substituted hydroxystilbenes as AhR and Nrf2 modulators and their therapeutic applications | Human Necessities | 0 | Active |
| US10166201B2 | Substituted hydroxystilbenes and their therapeutic applications | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.